跳至主要内容
临床试验/NCT03549780
NCT03549780已完成不适用

A Pilot Study of a Novel Stomal Occlusion Device in Patients With a Brooke Ileostomy

William A. Faubion, M.D.1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2019年8月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8
试验地点
1
主要终点
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

研究概览

简要总结

This investigation constitutes an initial evaluation of the stoma occlusion device in humans with a mature permanent Brooke ileostomy. The overall objective of this study is to assess feasibility and initial operating characteristics of a novel stoma occlusion device. The study will recruit 20 patients for placement of the device into the mature Brooke ileostomy and subsequent 2 hour observation period. The device will remain in the ileostomy for up to 2 hours.

详细描述

An ostomy is a protrusion of part of the intestines extending through the abdominal wall for the purpose of elimination of wastes and may be temporary or permanent depending on the purpose of the initial surgery. The most common reasons for permanent bowel diversion are cancer and ulcerative colitis. Appliances have improved greatly over the last 50 years, but patients continue to experience appliance leakage and skin infections and struggle with the emotional and social impact of an external pouch. This study seeks to answer the opportunity to significantly improve quality of life to a large segment of the global population through optimization of a technology for a stoma occlusion device in patients with permanent stomas. Four pre-clinical animal studies have been conducted. All the animals that completed the study tolerated the device well and had no adverse reactions to device materials. This project will allow a prototype of an artificial stomal occlusion device to be tested in humans.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age range: 18 and older
  • •Gender: Male and Female
  • •Target disease or condition: 20 patients with permanent End Ileostomy, specifically Brooke ileostomy for greater than 3 years
  • •Ability to comply with protocol
  • •Competent and able to provide written informed consent

排除标准

  • •Inability to provide consent
  • •Crohn's Disease
  • •Koch pouch
  • •Pregnancy
  • •If subject's stoma length is less than 4 cm or longer than 8 cm
  • •Clinically significant medical conditions within the six months before participation with the device that would, in the opinion of the investigators, compromise the safety of the patient.

研究组 & 干预措施

Stomal Occlusion

Other

Insertion of a novel stomal occlusion device into patients with Brooke Ileostomy and assess feasibility and patient satisfaction

干预措施: Stomal Occlusion Device (Device)

结局指标

主要结局

Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

时间窗: 2 hours

Safety: Device is able to be inserted adequately (function) and without any significant patient discomfort or adverse events (safety).

次要结局

  • Function (continence of device); observed leakage(2 hours)

研究者

发起方
William A. Faubion, M.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

William A. Faubion, M.D.

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验